BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishido K, Hakamada K, Kimura N, Miura T, Wakiya T. Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma. Ann Gastroenterol Surg 2021;5:7-23. [PMID: 33532676 DOI: 10.1002/ags3.12379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lafond M, Lambin T, Drainville RA, Dupré A, Pioche M, Melodelima D, Lafon C. Pancreatic Ductal Adenocarcinoma: Current and Emerging Therapeutic Uses of Focused Ultrasound. Cancers (Basel) 2022;14:2577. [PMID: 35681557 DOI: 10.3390/cancers14112577] [Reference Citation Analysis]
2 Ishido K, Kimura N, Wakiya T, Nagase H, Hara Y, Kanda T, Fujita H, Hakamada K. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma. Ann Surg Oncol 2021. [PMID: 34608555 DOI: 10.1245/s10434-021-10866-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wakiya T, Ishido K, Yoshizawa T, Kanda T, Hakamada K. Roles of the nervous system in pancreatic cancer. Ann Gastroenterol Surg 2021;5:623-33. [PMID: 34585047 DOI: 10.1002/ags3.12459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Stéphane H, Marianne G, Julie N, Patrizia L, Jean C, Patrice F, Pierre L. Opioid-free versus opioid-based anesthesia in pancreatic surgery. BMC Anesthesiol 2022;22:9. [PMID: 34983396 DOI: 10.1186/s12871-021-01551-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cilleros C, Dupré A, Chen Y, Vincenot J, Rivoire M, Melodelima D. Intraoperative HIFU Ablation of the Pancreas Using a Toroidal Transducer in a Porcine Model. The First Step towards a Clinical Treatment of Locally Advanced Pancreatic Cancer. Cancers (Basel) 2021;13:6381. [PMID: 34945001 DOI: 10.3390/cancers13246381] [Reference Citation Analysis]
6 Chen X, Tao Y, He M, Deng M, Guo R, Sheng Q, Wang X, Ren K, Li T, He X, Zang S, Zhang Z, Li M, He Q. Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cancer progression and metastasis. Theranostics 2021;11:8692-705. [PMID: 34522207 DOI: 10.7150/thno.60437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
7 Mima K, Hayashi H, Nakagawa S, Matsumoto T, Kinoshita S, Matsumura K, Kitamura F, Uemura N, Nakao Y, Itoyama R, Kaida T, Imai K, Yamashita YI, Baba H. Frailty is associated with poor prognosis after resection for pancreatic cancer. Int J Clin Oncol 2021. [PMID: 34235599 DOI: 10.1007/s10147-021-01983-z] [Reference Citation Analysis]
8 Kang MJ, Kim SW. Paradigm shift for defining the resectability of pancreatic cancer. Ann Hepatobiliary Pancreat Surg 2021;25:451-5. [PMID: 34845115 DOI: 10.14701/ahbps.2021.25.4.451] [Reference Citation Analysis]